Polomar Health Services Inc
trustfeed.comWhat Do They Do?
Fulfills prescriptions for compounded medications, including weight-loss and erectile-dysfunction drugs, for patients and online clinics.
10-K for FY2025, filed May 6, 2026The Company operates Polomar Specialty Pharmacy, LLC, a State of Florida licensed retail compounding pharmacy, located in Palm Harbor, FL…View ↗
The Company also owns SlimRx™ (www.slimrx.com), a weight loss focused online platform that the Company plans to launch in the second…View ↗
An integral part of the Company’s business model is to provide prescription fulfillment services to third party web based tele-health…View ↗
How Do They Make Money?
$648.2K
-
10-K for FY2025, filed May 6, 2026
$648.2K ↗
Who Are Their Customers?
Patients receive compounded prescriptions through the pharmacy, including prescriptions fulfilled for third-party online clinics and telehealth platforms.
10-K for FY2025, filed May 6, 2026
Do Revenues Turn Into Profits?
No. It lost $10.7M in FY2025.
10-K for FY2025, filed May 6, 2026
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 14, 2026
$200.4KView ↗
- ▲ Now profitable
- vs −$605.6K in Q2 FY2025
-
Jul 17, 2026
Changed its independent accounting firm
The company dismissed GreenGrowth CPAs and appointed Haskell & White LLP as its independent accounting firm.
Sources
8-K, filed Jul 17, 2026
On July 8, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors (the “Board”) of Polomar Health Services, Inc. (the…View ↗
-
Jun 15, 2026
Ended the Altanine merger and Pinata license agreements
The company and Altanine ended their merger agreement; the company also terminated the Pinata license, with remaining products permitted to be disposed of through September 7, 2026.
Sources
8-K, filed Jun 15, 2026
Additionally, in Section 4 of the Termination Agreement the Company and Pinata Holdings, Inc. (“Pinata”), a wholly owned subsidiary of…View ↗
Who Do They Compete With?
Competes with Hims/Hers, Ro, Eli Lily and, Levity Healthcare, and ZipHealth
10-K for FY2025, filed May 6, 2026The Company faces strong competition in the on-line prescription fulfillment marketplace, particularly for GLP-1 agonist weight loss drugs…View ↗
Loading...
